Ocugen seeks USFDA nod for phase 3 trials of Covaxin

We are very excited to take this next step in the development of COVAXIN: Ocugen CEO

Comments

Popular posts from this blog

Infosys lays off hundreds after failing internal assessments in Mysuru

Congress groomed me not to sit at home: Shivakumar

Greater Bengaluru Committee proposes seven municipal corporations